New Meta-analysis of Cepheid TB Test Shows Suboptimum Sensitivity in Kids | GenomeWeb

NEW YORK (GenomeWeb) – While Cepheid's GeneXpert MTB/RIF assay has the potential to provide rapid confirmation of tuberculosis infection in children younger than 16, its sensitivity is "suboptimum" and it does not effectively rule out TB, according to a meta-analysis published today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.